Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia
Clinical trial NCT04361032 · UNKNOWN
Trial details
- NCT number
- NCT04361032
- Sponsor
- Abderrahmane Mami Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-04
- Primary completion
- 2020-09-04
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.